Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 6 days agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 7 days agoBut longer-term sales are expected to be below 2024 estimates. It will be key to watch how the...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool via AOL· 2 days agoManagement predicts $4 billion in net cost savings by the end of 2024. In addition to lowered...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 7 days agoThe drug maker experienced a massive surge in sales and earnings during the COVID-19 pandemic's...
Salem CVS fined $75,000 for vaccine, drug violations in 2021, 2022
Roanoke Times· 6 days agoA teenager received a COVID-19 vaccine that amounted to six doses as once, according to state...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 4 days ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for...in...
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 14 hours agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 6 days agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 22 hours agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...